AzTrials
AzTrials

Aortic AneurysmNCT02438605

Dynamic CT Imaging After Nellix Endoprosthesis Implantation

An observational study of Aortic Aneurysm, run by Rijnstate Hospital at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Nellix Endovascular Sealing Prosthesis (EVAS) endoprosthesis is a new device aimed at prophylactic treatment of abdominal aortic aneurysms. In regular follow up conventional CT-imaging is used for surveillance. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Aortic Aneurysm
What is being tested?
Nellix
Type of treatment
Medical device
How many people
10 participants
Where
1 siteNetherlands
Study dates
Apr 2015to Feb 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Patients eligible for endovascular aortic repair using the Nellix endovascular sealing system

Who may be able to join

  • Nellix implantation

Who cannot join

  • Use of chimneys or combined with other stent graft material

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Rijnstate Hospital

    Arnhem, 6815AD

Other trials in Netherlands

About this study

The Nellix Endovascular Sealing Prosthesis (EVAS) endoprosthesis is a new device aimed at prophylactic treatment of abdominal aortic aneurysms. In regular follow up conventional CT-imaging is used for surveillance. In this study dynamic CT imaging in patients pre- and post-operative will be assessed for device changes and anatomical variances.

Conditions
Aortic Aneurysm
Being tested
Nellix
Keywords
Nellix, EVAS, EVAR, Dynamic CT, Dyna CT
Medical subject headings
Aortic Aneurysm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NellixDevice

Study groups in NCT02438605
Study groupRoleWhat they receive
Treatment groupPatients eligible for AAA repair using Nellix and willing to participate in this trial.
Receives: Device: Nellix

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in aortic aneurysm morphology as seen on dynamic CT after EVAS

    Measured: 1 month

Secondary outcomes (2)
  1. Dynamic changes in neck morphology after EVAS

    Measured: 1 month

  2. Dynamic changes in common iliac artery morphology after EVAS.

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2015 (estimated)
  2. Study startApr 2015
  3. Primary completionFeb 2016
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02438605
Sponsor's protocol ID
StM 596
Status last verified
Jun 2016
First submitted
6 May 2015
Last updated
1 Jul 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Aortic Aneurysm, run by Rijnstate Hospital at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in aortic aneurysm morphology as seen on dynamic CT after EVAS (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in